Go Pro
→ SpaceX Earnings Crash: The End of the AI Bubble? (From TradeSmith) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$0.80
0.0%		$0.88
$0.70
▼
$1.72
$314.10M1.41.89 million shs728,965 shs
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$1.73
-16.8%		$1.90
$1.66
▼
$4.94
$96.03M1.44204,342 shs1.44 million shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$18.32
-0.1%		$17.86
$11.09
▼
$21.01
$370.92M1.32443,400 shs156,992 shs
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
$6.46
-1.1%		$5.23
$1.91
▼
$6.68
$350.10M0.64125,147 shs151,403 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-0.01%-7.83%-9.25%-21.57%-37.50%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-16.83%-18.78%+0.58%-34.22%-49.27%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-0.11%+0.49%+0.27%+9.83%+40.49%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-1.07%+29.20%+25.44%+68.67%+48.51%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$0.80
0.0%		$0.88
$0.70
▼
$1.72
$314.10M1.41.89 million shs728,965 shs
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$1.73
-16.8%		$1.90
$1.66
▼
$4.94
$96.03M1.44204,342 shs1.44 million shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$18.32
-0.1%		$17.86
$11.09
▼
$21.01
$370.92M1.32443,400 shs156,992 shs
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
$6.46
-1.1%		$5.23
$1.91
▼
$6.68
$350.10M0.64125,147 shs151,403 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-0.01%-7.83%-9.25%-21.57%-37.50%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-16.83%-18.78%+0.58%-34.22%-49.27%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-0.11%+0.49%+0.27%+9.83%+40.49%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-1.07%+29.20%+25.44%+68.67%+48.51%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Standard BioTools Inc. stock logo
LAB
Standard BioTools
1.67
Reduce$1.3568.75% Upside
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
2.33
Hold$6.00246.82% Upside
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
1.88
Reduce$17.25-5.84% Downside
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
2.00
Hold$7.008.36% Upside

Current Analyst Ratings Breakdown

Latest RPID, SLP, LAB, and TKNO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/6/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
8/5/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$7.00
8/5/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$7.00
7/21/2026
Standard BioTools Inc. stock logo
LAB
Standard BioTools
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
7/17/2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/17/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/10/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
6/18/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$18.50
6/17/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
6/5/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D-) ➝ Sell (D)
5/29/2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$8.00 ➝ $5.00
(Data available from 8/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$85.33M3.68N/AN/A$1.38 per share0.58
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$33.59M2.38N/AN/A$0.75 per share2.31
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$79.18M4.68$1.43 per share12.81$6.20 per share2.95
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
$40.52M8.55N/AN/A$1.28 per share5.05
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$74.90M$0.223.64N/AN/A100.36%-7.57%-6.14%N/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$47.12M-$1.12N/AN/AN/A-145.81%-131.52%-67.48%N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-$64.72M$0.4045.80N/AN/A9.88%13.50%12.45%N/A
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-$17.26M-$0.32N/AN/AN/A-38.37%-24.38%-16.24%N/A

Latest RPID, SLP, LAB, and TKNO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q2 2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$0.2433-$0.27-$0.0267-$0.27$7.88 million$8.05 million
8/5/2026Q2 2026
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$0.0128-$0.07-$0.0573-$0.07$20.80 million$20.10 million
8/5/2026Q2 2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-$0.0843-$0.06+$0.0243-$0.06$10.95 million$12.19 million
7/9/2026Q3 2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.2325$0.30+$0.0675$0.18$20.90 million$21.89 million
5/13/2026Q1 2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$0.25-$0.31-$0.06-$0.31$7.60 million$8.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/AN/AN/AN/AN/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
N/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/AN/A-100.00%N/AN/A
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/A
9.10
11.92
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
0.93
2.57
1.66
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/A
5.54
5.54
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
0.20
4.59
3.60

Institutional Ownership

CompanyInstitutional Ownership
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.74%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
52.60%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
78.08%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
13.81%

Insider Ownership

CompanyInsider Ownership
Standard BioTools Inc. stock logo
LAB
Standard BioTools
26.81%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
12.70%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
19.10%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
13.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Standard BioTools Inc. stock logo
LAB
Standard BioTools
620392.58 million285.71 millionOptionable
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
20046.17 million40.31 millionNot Optionable
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
16020.23 million16.36 millionOptionable
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
24053.61 million46.54 millionNot Optionable

Recent News About These Companies

Alpha Teknova (NASDAQ:TKNO) Raised to Hold at Zacks Research
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-raised-to-hold-at-zacks-research-2026-08-08/
Alpha Teknova (NASDAQ:TKNO) Research Coverage Started at Roth Capital
August 8 at 3:07 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30948195
Alpha Teknova (NASDAQ:TKNO) Upgraded to "Buy" at Wall Street Zen
August 8 at 1:43 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30947508
Alpha Teknova (NASDAQ:TKNO) Upgraded at Wall Street Zen
August 8 at 1:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-upgraded-at-wall-street-zen-2026-08-08/
Alpha Teknova (TKNO) Stock Moves Higher on Booming Clinical Demand
August 7 at 10:11 AM  |  insidermonkey.comhttps://www.insidermonkey.com/blog/alpha-teknova-tkno-stock-moves-higher-on-booming-clinical-demand-1807999/
Teknova targets less than $8M 2026 free cash outflow as it lifts revenue guide to $45M-$47M
August 6 at 9:35 AM  |  seekingalpha.comhttps://seekingalpha.com/news/4627100-teknova-targets-less-than-8m-2026-free-cash-outflow-as-it-lifts-revenue-guide-to-45m-47m
Roth Capital Upgrades Alpha Teknova (NASDAQ:TKNO) to Strong-Buy
August 6 at 8:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/roth-capital-upgrades-alpha-teknova-nasdaqtkno-to-strong-buy-2026-08-06/
Alpha Teknova Q2 Earnings Call Highlights
August 6 at 2:02 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-q2-earnings-call-highlights-2026-08-06/
Alpha Teknova (NASDAQ:TKNO) Issues Earnings Results, Beats Estimates By $0.02 EPS
August 5 at 7:55 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-issues-earnings-results-beats-estimates-by-002-eps-2026-08-05/
Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
August 5 at 6:37 PM  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/teknova-launches-build-tek-a-proprietary-ai-reagent-assistant-that-allows-customers-to-configure-complex-custom-product-requests-in-minutes-1036413072
Teknova Reports Second Quarter 2026 Financial Results
August 5 at 4:01 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339649/0/en/teknova-reports-second-quarter-2026-financial-results.html
Alpha Teknova (TKNO) to Release Quarterly Earnings on Wednesday
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-tkno-to-release-quarterly-earnings-on-wednesday-2026-07-29/
Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/22/3331688/0/en/teknova-to-report-second-quarter-2026-financial-results-on-august-5-2026.html
Alpha Teknova, Inc. $TKNO Holdings Boosted by Roubaix Capital LLC
July 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-alpha-teknova-inc-tkno-holdings-boosted-by-roubaix-capital-llc-2026-07-19/
Alpha Teknova (NASDAQ:TKNO) Shares Down 2.2% - What's Next?
July 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-shares-down-22-whats-next-2026-07-16/
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Arcus Biosciences (RCUS) and Tenaya Therapeutics (TNYA)
June 4, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2309178/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-arcus-biosciences-rcus-and-tenaya-therapeutics-tnya/
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and REPRO-MED Systems (KRMD)
May 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TKNO/pressreleases/1763703/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-and-repro-med-systems-krmd/
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/alpha-teknova-inc-nasdaq-tkno-142331465.html
Alpha Teknova, Inc. (TKNO) Q1 2026 Earnings Call Transcript
May 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4901691-alpha-teknova-inc-tkno-q1-2026-earnings-call-transcript
Alpha Teknova Charts Cautious Path to 2027 Growth
May 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/alpha-teknova-charts-cautious-path-to-2027-growth?utm_source=marketbeat.com&utm_medium=referral
Alpha Teknova (TKNO) Q1 2026 Earnings Transcript
May 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/alpha-teknova-tkno-q1-2026-230740509.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Rocket Lab Electron rocket on coastal launch pad with company logo overlay, symbolizing space tech integration strategy.
Rocket Lab’s Stock Drop Comes With a Bullish Twist
By Ryan Hasson | July 10, 2026
Abbott logo displayed on a glass office building exterior at the company's headquarters.
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
By Thomas Hughes | July 16, 2026
Illustration of a space station with solar panels orbiting Earth against a starry background.
3 Space Stocks That Could Outshine SpaceX After Its IPO
By Chris Markoch | July 14, 2026
AST SpaceMobile logo above a satellite in orbit over Earth, highlighting space-based wireless expansion.
AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
By Jessica Mitacek | July 17, 2026
Illustration of colorful fiber optic cables feeding into a metal connector labeled "AI Co." inside a data center.
Beyond the Foundry: 5 Infrastructure Stocks Tackling the AI Bottlenecks
By Thomas Hughes | July 14, 2026
Standard BioTools stock logo

Standard BioTools NASDAQ:LAB

$0.80 0.00 (-0.01%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$0.81 +0.01 (+1.75%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Rapid Micro Biosystems stock logo

Rapid Micro Biosystems NASDAQ:RPID

$1.73 -0.35 (-16.83%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$1.80 +0.06 (+3.76%)
As of 08/7/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Simulations Plus stock logo

Simulations Plus NASDAQ:SLP

$18.32 -0.02 (-0.11%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$18.32 0.00 (-0.03%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Alpha Teknova stock logo

Alpha Teknova NASDAQ:TKNO

$6.46 -0.07 (-1.07%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$6.45 -0.01 (-0.15%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas